top of page

AROMASIN (exemestane tablets) is a prescription medicine for:

  • Early breast cancer: AROMASIN is indicated for the adjuvant treatment (additional treatment given after the primary or main treatment) of postmenopausal women with estrogen-receptor positive (ER positive) early breast cancer. Treatment with AROMASIN should begin 2 to 3 years after tamoxifen, at which time tamoxifen should be stopped. Treatment with AROMASIN should continue for 2 to 3 years until a total of 5 years of adjuvant treatment of tamoxifen and AROMASIN have been completed.
  • Advanced breast cancer: AROMASIN is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen therapy.



bottom of page